Tags

Type your tag names separated by a space and hit enter

[Other antihyperuricemic agents].
Nihon Rinsho. 2008 Apr; 66(4):754-7.NR

Abstract

It has been reported that hyperuricemia might be responsible for cardiovascular diseases as well as gout and renal injury. Hypertension and hyperlipidemia, which are also responsible for cardiovascular diseases, are often associated with hyperuricemia. Thus, the treatment of hypertension and hyperlipidemia associated with hyperuricemia is also important. Losartan, an antihypertensive agent, and fenofibrate, an antihyperlipidemic agent, are known to have uric acid lowering effects. Both agents are useful for hyperuricemia with associated with hypertension and hyperlipidemia. In this section, we reported the characteristics and usefulness of these two agents in hyperuricemic patients with hypertension and hyperlipidemia.

Authors+Show Affiliations

Center for Clinical Residency Program, Tottori University Hospital.No affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

jpn

PubMed ID

18409527

Citation

Ogino, Kazuhide, et al. "[Other Antihyperuricemic Agents]." Nihon Rinsho. Japanese Journal of Clinical Medicine, vol. 66, no. 4, 2008, pp. 754-7.
Ogino K, Igawa O, Hisatome I. [Other antihyperuricemic agents]. Nihon Rinsho. 2008;66(4):754-7.
Ogino, K., Igawa, O., & Hisatome, I. (2008). [Other antihyperuricemic agents]. Nihon Rinsho. Japanese Journal of Clinical Medicine, 66(4), 754-7.
Ogino K, Igawa O, Hisatome I. [Other Antihyperuricemic Agents]. Nihon Rinsho. 2008;66(4):754-7. PubMed PMID: 18409527.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Other antihyperuricemic agents]. AU - Ogino,Kazuhide, AU - Igawa,Osamu, AU - Hisatome,Ichiro, PY - 2008/4/16/pubmed PY - 2008/5/31/medline PY - 2008/4/16/entrez SP - 754 EP - 7 JF - Nihon rinsho. Japanese journal of clinical medicine JO - Nihon Rinsho VL - 66 IS - 4 N2 - It has been reported that hyperuricemia might be responsible for cardiovascular diseases as well as gout and renal injury. Hypertension and hyperlipidemia, which are also responsible for cardiovascular diseases, are often associated with hyperuricemia. Thus, the treatment of hypertension and hyperlipidemia associated with hyperuricemia is also important. Losartan, an antihypertensive agent, and fenofibrate, an antihyperlipidemic agent, are known to have uric acid lowering effects. Both agents are useful for hyperuricemia with associated with hypertension and hyperlipidemia. In this section, we reported the characteristics and usefulness of these two agents in hyperuricemic patients with hypertension and hyperlipidemia. SN - 0047-1852 UR - https://www.unboundmedicine.com/medline/citation/18409527/[Other_antihyperuricemic_agents]_ L2 - https://medlineplus.gov/cholesterolmedicines.html DB - PRIME DP - Unbound Medicine ER -